Center for Dementia Research, Nathan Kline Institute, 140 Old Orangeburg Road, Orangeburg, NY, 10962, 845-398-2170, USA.
Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.
Acta Neuropathol Commun. 2024 Nov 27;12(1):182. doi: 10.1186/s40478-024-01891-z.
Selective vulnerability of neuronal populations occurs in both Down syndrome (DS) and Alzheimer's disease (AD), resulting in disproportional degeneration of pyramidal neurons (PNs) affecting memory and executive function. Elucidating the cellular mechanisms underlying the selective vulnerability of these populations will provide pivotal insights for disease progression in DS and AD. Single population RNA-sequencing analysis was performed on neurons critical for executive function, prefrontal cortex Brodmann area 9 (BA9) layer III (L3) and layer V (L5) excitatory PNs in postmortem human DS and age- and sex-matched control (CTR) brains. Data mining was performed on differentially expressed genes (DEGs) from PNs in each lamina with DEGs divergent between lamina identified and interrogated. Bioinformatic inquiry of L3 PNs revealed more unique/differentially expressed DEGs (uDEGs) than in L5 PNs in DS compared to CTR subjects, indicating gene dysregulation shows both spatial and cortical laminar projection neuron dependent dysregulation. DS triplicated human chromosome 21 (HSA21) comprised a subset of DEGs only dysregulated in L3 or L5 neurons, demonstrating partial cellular specificity in HSA21 expression. These HSA21 uDEGs had a disproportionally high number of noncoding RNAs, suggesting lamina specific dysfunctional gene regulation. L3 uDEGs revealed overall more dysregulation of cellular pathways and processes, many relevant to early AD pathogenesis, while L5 revealed processes suggestive of frank AD pathology. These findings indicate that trisomy differentially affects a subpopulation of uDEGs in L3 and L5 BA9 projection neurons in aged individuals with DS, which may inform circuit specific pathogenesis underlying DS and AD.
在唐氏综合征 (DS) 和阿尔茨海默病 (AD) 中,神经元群体都存在选择性易损性,导致影响记忆和执行功能的锥体神经元 (PNs) 不成比例退化。阐明这些群体选择性易损性的细胞机制将为 DS 和 AD 中的疾病进展提供关键见解。对执行功能关键的神经元进行了单细胞 RNA 测序分析,分别来自尸检 DS 患者和年龄及性别匹配的对照 (CTR) 大脑的前额叶皮质 Brodmann 区域 9 (BA9) 第 3 层 (L3) 和第 5 层 (L5) 兴奋性 PNs。对每个层的 PN 中的差异表达基因 (DEGs) 进行了数据挖掘,与层间差异鉴定和询问的 DEGs 不同。L3 PN 的生物信息学探究显示,与 CTR 相比,DS 中 L3 的 uDEGs 比 L5 更多,表明基因失调不仅表现出空间和皮质层状投射神经元的依赖性失调。DS 三倍体人类 21 号染色体 (HSA21) 仅在 L3 或 L5 神经元中失调的 DEGs 组成了一个子集,表明 HSA21 表达具有部分细胞特异性。这些 HSA21 uDEGs 的非编码 RNA 数量不成比例地高,表明层特异性的基因调控功能失调。L3 uDEGs 显示细胞途径和过程的整体失调更多,许多与早期 AD 发病机制有关,而 L5 则显示出明显 AD 病理学的过程。这些发现表明,在患有 DS 的老年个体中,HSA21 在 L3 和 L5 BA9 投射神经元中差异影响了 uDEGs 的亚群,这可能为 DS 和 AD 提供特定于回路的发病机制信息。